Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 6Dermatologic 2Sarcoma 1Lymphoid 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Rhabdomyosarcoma 1Recurrence 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Diseases 1Neuroblastoma 1Neoplasm Metastasis 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1Fibrosis 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma 1Breast Neoplasms 1Basal Cell Nevus Syndrome 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 7X-Rays 6Specimen Handling 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Carboplatin 4Biopsy 4Thiotepa 3Temozolomide 3Melphalan 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Busulfan 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2etoposide phosphate 2erdafitinib 2ensartinib 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × sonidegib × Gastrointestinal × Clear all
NCT01125800 2017-03-20

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

Novartis

Phase 1/2 Completed
76 enrolled 18 charts
CNSGastrointestinalSarcoma

Astrocytoma, Glioma, Medulloblastoma, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡